$4.34
-0.07-1.59%
Last update: 11:19 AM
15 minutes delayed
Comments
Loading...
Monopar Therapeutics (MNPR) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMonopar Therapeutics (NASDAQ:MNPR) Stock Quotes, Forecast and News Summary
Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Monopar Therapeutics (MNPR) stock?
You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.
Who are Monopar Therapeutics (MNPR) competitors?
Other companies in Monopar Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?
Monopar Therapeutics has a consensus price target of $10.75.
What is the current price for Monopar Therapeutics (MNPR)?
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $4.34 last updated September 25, 2024 at 11:19 AM EDT.
Does Monopar Therapeutics (MNPR) pay a dividend?
There are no upcoming dividends for Monopar Therapeutics.
When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?
Monopar Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Monopar Therapeutics (MNPR) going to split?
There is no upcoming split for Monopar Therapeutics.
What sector and industry does Monopar Therapeutics (MNPR) operate in?
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.